Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionality.
Ochoa-de-Olza M, Rayroux N, Imbimbo M, Orcurto A, Fahr N, Benedetti F, Dagher J, Spagnol G, Barras D, Ghisoni E, Navarro B, Mulvey A, Berthold D, Sarivalasis A, Zaman K, Stravodimou A, Digklia A, Duran R, Dromain C, Prior JO, Schaefer N, Zimmermann S, Obeid M, Chalkidis N, Zoi T, Bisig B, Trueb L, Gulhan DC, Sempoux C, Dafni U, Tissot S, Coukos G, Herrera FG, Dangaj Laniti D.
Ochoa-de-Olza M, et al. Among authors: schaefer n.
Clin Cancer Res. 2026 Apr 17. doi: 10.1158/1078-0432.CCR-25-2743. Online ahead of print.
Clin Cancer Res. 2026.
PMID: 41995577